163 filings
Page 2 of 9
SC 13E3
mec47341k9q98t
8 Mar 24
Going private transaction
5:32pm
SC 14D9
23poyw
8 Mar 24
Tender offer solicitation
5:21pm
SC TO-T
dfj0c41v
8 Mar 24
Third party tender offer statement
4:53pm
SC14D9C
os8wl6o ofovdlmw7k
26 Feb 24
Written communication relating to third party tender offer
5:11pm
8-K
52bh5cq4mmf9y
26 Feb 24
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
5:01pm
SC TO-C
95arph1x036y8w1dddw
26 Feb 24
Information about tender offer
4:53pm
8-K
2398mffia 766
22 Jan 24
Other Events
6:09am
8-K
h518f1dwrwgv
2 Jan 24
Other Events
7:30am
8-K
77nk8xka a36
4 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
t9cfgv7 rpuo6qfo73j
2 Nov 23
NGM Bio Reports Third Quarter 2023 Financial Results and Provides Business Highlights
4:06pm
8-K
xdvtji2jy 4ivyjmlk9
17 Oct 23
Departure of Directors or Certain Officers
5:28pm
8-K/A
gimxc6
11 Sep 23
Departure of Directors or Certain Officers
4:01pm
8-K
rbi2uhzt
11 Aug 23
Departure of Directors or Certain Officers
4:08pm
EFFECT
2oh3aw wvcp3
7 Aug 23
Notice of effectiveness
12:15am
424B5
1vv1zfc
4 Aug 23
Prospectus supplement for primary offering
5:01pm
S-3/A
z1gjcvcpq7k4qb4k3
4 Aug 23
Shelf registration (amended)
4:01pm
8-K
aw69gn582q2ii zkqv
3 Aug 23
NGM Bio Reports Second Quarter 2023 Financial Results and Provides Business Highlights
4:07pm
CORRESP
lin9e7
1 Aug 23
Correspondence with SEC
12:00am